# 贝如塔医院 Beta Hospital

> ResidualPlay case file: an overlooked Steam game still earning residual revenue. Estimates carry a ±30-50% error range per title.

- Steam appid: 3345960
- Developer: 逃跑灵羊工作室
- Released: 2025 · Genre: Adventure · List price: $2.78
- Deal grade: D (A = dormant with >=$5k/mo opportunity, D = low signal)
- Est. net residual revenue: $53 to $79 per month (mid $66)
- Opportunity score: $66/month at x1.00 dormancy multiplier
- Est. lifetime owners: 11.6k · Est. lifetime net revenue: $10.8k
- Review sentiment: 84% positive across 381 reviews (361 from Steam purchases)
- Review velocity: 2.8 reviews/month (6-month average)

## Why it's flagged

- Developer active, last post 1 months ago
- Last build shipped 1 months ago
- Store page localized in only 2 language(s)
- Last discounted 1 months ago, 6 sales in the last 12 months

## Where a gross dollar goes (monthly, at current velocity)

| Stage | USD/month |
|---|---|
| Gross storefront sales | $120 |
| After VAT / sales tax (-13% blended) | $104 |
| After refunds (-9.5% median) | $94 |
| Net to developer (after Steam 30%) | $66 |

## Monthly review counts, oldest to newest (17 months)

254, 31, 12, 13, 8, 13, 8, 6, 1, 10, 5, 3, 4, 3, 1, 4, 2

## Missed seasonal-sale revenue (modeled)

Skipped 4 Steam seasonal sale window(s) in the last 17 months. Running a -50% discount in those windows is modeled at +$3.2k net in total, assuming a unit uplift of x3.0 (industry-typical for old catalog titles). Same ±30-50% error range applies.

## Methodology

Units are estimated from Steam-purchase reviews times a release-cohort multiplier (Boxleiter method, 20-75x by year). Revenue uses an effective price (lifetime discounts and regional pricing) and nets out VAT (~13%), refunds (~9.5%) and Steam's 30% cut: roughly 55% of gross reaches the developer.

Source: https://residualplay.com/game/3345960
Citation: please cite ResidualPlay (https://residualplay.com) when using these estimates.